期刊名称：JAPANESE JOURNAL OF CLINICAL ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Japanese Journal of Clinical Oncology (JJCO) was established in 1971 by Dr Masaru Kuru, the third President of the National Cancer Center (NCC) and also the first Director of the National Cancer Center Hospital, who felt at that time a strong need for an international journal of clinical oncology from Japan.
The late Dr Kempo Tsukamoto, the fourth President of the NCC, served as the first Editor-in-Chief from 1971 to 1974. He was succeeded by the late Dr Shichiro Ishikawa, the sixth President, who served from 1974 to 1986. Dr Takashi Sugimura, the seventh President of the NCC, is now Editor Emeritus, having served from 1986 until 1995.
For the first 10 years after its establishment, JJCO was a biannual journal. After steady growth in the number of both papers and subscribers, it became quarterly in 1983 and bimonthly in 1991, publishing original articles, reviews, case reports and epidemiological notes. We put emphasis on publishing case reports and clinical investigations with various clinical implications, even when they represent negative results. We also encourage those authors who are working on frontier subjects to put forward their views, even when they do not have enough data to confirm their ideas.
We are further pleased to anounce the latest step in keeping JJCO abreast of information technology; from volume 27, JJCO is published not only in hardcopy, but also in electronic form on the Internet.
As the first English journal from Japan to publish clinical research on cancer, JJCO aimed to introduce to the world some of the significant contributions in this field, and is now playing an important role in this respect. At the same time, with its reputation established, it is attracting many papers from foreign countries, especially from the growing research communities of Asia. With our journal now much more accessible on the Internet, we wish JJCO to become more international and welcome submissions from around the world.
We anticipate that these new steps taken by JJCO will help it enter a new stage of development for the 21st century.
The Japanese Journal of Clinical Oncology publishes original articles and case reports written in English related to clinical research on cancer and allied fields. Reviews, meeting reports and epidemiology notes are sometimes included at the Editor's request. Letters to the Editor, commenting on articles published previously in the Journal or expressing views on topics relevant to clinical oncology, will be published if appropriate. Papers which have already been published or are expected to be published concurrently in other journals, in either Japanese or English, will not be accepted. Decisions on whether or not to accept papers are made by the Editorial Committee.
Instructions to Authors
Preparation of manuscript
Manuscript format and style should be in accordance with the `Uniform Requirements for Manuscripts Submitted to Biomedical Journals' (JAMA 1993;269:2282-6).
The original manuscript together with three copies is required. Type the manuscript on A4 white paper with margins of at least 25 mm. Use double-spacing throughout, including title page, abstract, text, acknowledgments, references, individual tables and legends. Number pages consecutively, beginning with the title page. Manuscripts must be accompanied by a covering letter signed by all coauthors.
Title page
The title page should carry a) the title of the article, which should be concise but informative; b) first name, middle initial, and last names of each author with institutional affiliation; c) name of department(s) and institution(s) to which the work should be attributed; d) name and address of author responsible for correspondence about the manuscript, with phone and fax numbers and E-mail address if available; e) a running head of no more than 40 characters (count letters and spaces) placed at the foot of the title page and identified.
Abstract and key words
The second page should carry an abstract of no more than 250 words. The abstract should state the purposes of the study, basic procedures, main findings, and the principal conclusions. New and important aspects of the study or observations should be emphasized. No abbreviations, footnotes or references are to be used in the abstract.
Below the abstract provide three to five key words that will assist indexers in cross-indexing the article and may be published with the abstract. Use terms from the medical subject headings (MeSH) list of Index Medicus.
Text
The text of each original article should be divided into sections with the headings Introduction, Materials and Methods, Results, and Discussion. Long articles may need subheadings within some sections to clarify their content.
References
Number references consecutively in the order in which they are first mentioned in the text. References cited only in tables or in legends should be numbered in accordance with a sequence established by the first identification in the text of the particular table or figure.
The titles of journals should be abbreviated according to the style used in Index Medicus. Include in the references papers accepted but not yet published; designate the journal and add `In press'. Information from manuscripts submitted but not yet accepted should be cited in the text as `unpublished observations' (in parentheses).
References should be written according to the following examples. List all authors, but if the number exceeds six, give six followed by `et al.' The references must be verified by the author(s) against the original documents. When citation of articles written in Japanese is unavoidable, follow the style of example No. 3 below.
1. Takayama T, Kato H, Tachimori Y, Watanabe H, Furukawa H, Takayasu K, et al. Treatment of rupture of a liver metastasis from esophageal leiomyosarcoma. Jpn J Clin Oncol 1996;26:248-51.
2. Lowy AM, Beech DJ. Oncologic surgical emergencies. In: Berger DH, Feig BW, Fuhrman GM, editors. The M.D. Anderson Surgical Oncology Handbook. Boston: Little Brown 1995;369-91.
3. Yosimoto M, Tada T, Kasumi F. Recent progress in the diagnosis of nonpalpable breast lesions. Nippon Geka Gakkai Zasshi 1996;97:343-6 (in Japanese).
Tables
Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all nonstandard abbreviations that are used in each table. For footnotes use the following symbols, in this sequence: *, {, }, w, W, k. If you use data from another published or unpublished source, obtain permission and acknowledge fully.
Figures
Submit four complete sets of figures. Figures should be professionally drawn and photographed; freehand or typewritten lettering is unacceptable. In general, photographs should fit within a single column width (80 y 75 or 115 mm) or two column widths (170 y 115 or 230 mm). Letters, numbers and symbols should be clear and even throughout and of sufficient size that when reduced for publication each item will still be legible. Computer-finished illustrations of high quality may be acceptable if printed clearly by a laser printer. Titles and detailed explanations belong in the legends for figures, not on the illustrations themselves.
Photographs should be submitted unmounted; however, if authors wish to have a group of photographs printed together in a single block (composite figure), one set may be mounted on a plate to show the preferred layout. Each section of the composite figure may be lettered `a', `b', `c', etc. in the lower right-hand corner. Symbols, arrows, or letters used in photomicrographs should contrast with the background.
Figures should be numbered consecutively according to the order in which they have been first cited in the text. Each figure should have a label pasted on its back indicating the figure number, first author's name, and the orientation of the top of the figure. If a figure has been published, acknowledge the original source and submit written permission from the copyright holder to reproduce the material.
Color photographs will be published only when the Editor deems them indispensable, with the full cost borne by the author.
Type legends for illustrations double-spaced, starting on a separate page, with Arabic numerals corresponding to the illustrations. When symbols, arrows, numbers, or letters are used to identify parts of the illustrations, identify and explain each one clearly in the legend.
Units of measurement
Measurements of length, height, weight and volume should be reported in metric units (meter, kilogram or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury.
All hematological and clinical chemistry measurements should be reported using the metric system in terms of the International System of Units (SI), but authors may include older conventional units in parentheses if desired.
Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement. If many abbreviations are used, they should also be listed and explained at the foot of the first page of the text.
Statistics
Describe which statistical methods were used for which analyses. For detailed guidance, consult Jpn J Clin Oncol 1997; 27 (3) 121-127.
Submission on disks
After the manuscript has been accepted, authors should submit the final version on disk together with an identical hard copy. Disks in MS-DOS, Windows or Macintosh format are acceptable. Detailed guidelines for electronic submission will be sent with the notice of acceptance.
Reprints
Authors are provided with 50 reprints of each published paper free of charge. Additional reprints are available at the author's expense in multiples of 50 (minimum 100 copies). Reprint order forms are sent to authors along with their galley proofs.
Editorial Board
Editor-in-Chief: Tadao Kakizo
Editors Emeritus: Takashi Sugimura, Kaoru Abe
Consulting Editors: Michiya Ohtaka, Haruo Sugano
Executive Editor: Takeshi Sano
Deputy Editor: Soichiro Shibui
News Editor: Hisao Asamura
Production Editor: Shuichi Okada
Cover Editor: Kyosuke Ushio
Managing Editor: Masako Noda
Editorial Office
National Cancer Center
5-1-1 Tsukiji
Chuo-ku
Tokyo 104-0045
Japan
Editorial correspondence
Editorial Office : Japanese Journal of Clinical Oncology
c/o National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104, Japan
Phone 03 3542 2511 Ext. 2420, Fax 03 3543 2476
Email: jjco@ncc.go.jp
| 
刊名字顺( Alphabetical List of Journals):
返回页首 